Cubist Systematic Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.13M Buy
11,900
+9,100
+325% +$837K 0.01% 1892
2025
Q2
$244K Sell
2,800
-1,100
-28% -$93.3K ﹤0.01% 2532
2025
Q1
$350K Sell
3,900
-2,500
-39% -$224K ﹤0.01% 2318
2024
Q4
$511K Buy
6,400
+2,500
+64% +$216K ﹤0.01% 2166
2024
Q3
$351K Sell
3,900
-70,600
-95% -$5.94M ﹤0.01% 2355
2024
Q2
$5.86M Sell
74,500
-47,800
-39% -$3.92M 0.04% 680
2024
Q1
$10.7M Sell
122,300
-23,000
-16% -$1.96M 0.06% 492
2023
Q4
$12M Buy
145,300
+50,900
+54% +$3.88M 0.08% 359
2023
Q3
$7.4M Sell
94,400
-13,100
-12% -$1.1M 0.05% 531
2023
Q2
$9.47M Sell
107,500
-128,200
-54% -$11M 0.06% 460
2023
Q1
$19M Buy
235,700
+113,300
+93% +$9.23M 0.12% 171
2022
Q4
$9.51M Buy
122,400
+38,100
+45% +$3.09M 0.06% 517
2022
Q3
$6.81M Buy
84,300
+59,800
+244% +$5.37M 0.04% 784
2022
Q2
$2.2M Buy
+24,500
New +$2.48M 0.01% 1765

Other funds holding MDT

Cubist Systematic Strategies's MDT Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Medtronic (MDT) in Q2 2025, closing a stake of 9,132 shares — an estimated $774K sold.

Cubist Systematic Strategies first reported a position in MDT in Q2 2014 and held it in 39 quarters. The position peaked at $36.2M in Q4 2021. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 9,132 Medtronic shares in Q2 2025, an estimated $774K.
  • Cubist Systematic Strategies first reported a position in Medtronic in Q2 2014 and held it in 39 quarters.
  • Cubist Systematic Strategies's Medtronic position peaked at $36.2M in Q4 2021.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.